Latest News about MCRB
Recent news which mentions MCRB
Earnings Scheduled For March 1, 2022
March 01, 2022
From Benzinga
Seres Therapeutics' Oral Microbiome Candidate Shows Meaningful Improvements In Difficile Infection
January 20, 2022
Tickers
MCRB
From Benzinga
Jim Cramer Shares His Thoughts On Novavax, ViacomCBS And More
December 06, 2021
From Benzinga
52 Biggest Movers From Yesterday
December 01, 2021
From Benzinga
Why Shares of Seres Therapeutics Rose More Than 21% on Tuesday
November 30, 2021
Tickers
MCRB
From Motley Fool
35 Stocks Moving In Tuesday's Mid-Day Session
November 30, 2021
From Benzinga
Looking Into Seres Therapeutics's Return On Capital Employed
November 11, 2021
Tickers
MCRB
From Benzinga
76 Biggest Movers From Yesterday
November 11, 2021
From Benzinga
Why Shares of Seres Therapeutics Are Up More Than 22% Wednesday
November 10, 2021
From Motley Fool
Mid-Afternoon Market Update: Nasdaq Tumbles 300 Points; PubMatic Shares Gain After Q3 Results
November 10, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 10, 2021
From Benzinga
Mid-Morning Market Update: Markets Edge Lower; US Inflation Rate Increases To 6.2%
November 10, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 10, 2021
From Benzinga
53 Biggest Movers From Yesterday
September 16, 2021
From Benzinga
Why Seres Therapeutics Stock Is Soaring Today
September 15, 2021
From Motley Fool
Why Seres Therapeutics Shares Are Trading Higher Today
September 15, 2021
Tickers
MCRB
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 15, 2021
From Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
From Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
From Benzinga
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Friday
August 27, 2021
From Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.